Summit X LLC’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,106
Closed -$522K 266
2020
Q4
$522K Buy
+6,106
New +$505K 0.15% 144
2020
Q2
$471K Buy
6,426
+155
+2% +$11K 0.17% 123
2020
Q1
$413K Buy
6,271
+50
+0.8% +$3.53K 0.19% 114
2019
Q4
$432K Buy
6,221
+251
+4% +$17.1K 0.16% 150
2019
Q3
$440K Buy
5,970
+430
+8% +$31.2K 0.18% 144
2019
Q2
$395K Buy
5,540
+140
+3% +$9.94K 0.16% 157
2019
Q1
$373K Buy
5,400
+126
+2% +$8.14K 0.16% 159
2018
Q4
$312K Sell
5,274
-22
-0.4% -$1.38K 0.18% 156
2018
Q3
$353K Buy
5,296
+116
+2% +$7.73K 0.17% 155
2018
Q2
$335K Buy
5,180
+156
+3% +$10.2K 0.19% 140
2018
Q1
$355K Buy
5,024
+201
+4% +$14.5K 0.21% 128
2017
Q4
$369K Buy
4,823
+27
+0.6% +$1.97K 0.23% 128
2017
Q3
$349K Buy
4,796
+205
+4% +$14.8K 0.23% 127
2017
Q2
$341K Buy
+4,591
New +$341K 0.24% 126

Other funds holding CL

Summit X LLC's CL Position: Q1 2021 in Review

Summit X LLC sold out of Colgate-Palmolive (CL) in Q1 2021, closing a stake of 6,106 shares — an estimated $522K sold.

Summit X LLC first reported a position in CL in Q2 2017 and held it in 14 quarters. The position peaked at $522K in Q4 2020. 1,608 funds tracked by Wall St. Rank hold CL as of Q1 2021.

  • Summit X LLC reported no remaining Colgate-Palmolive position as of Q1 2021 after selling out during the quarter.
  • Summit X LLC sold 6,106 Colgate-Palmolive shares in Q1 2021, an estimated $522K.
  • Summit X LLC first reported a position in Colgate-Palmolive in Q2 2017 and held it in 14 quarters.
  • Summit X LLC's Colgate-Palmolive position peaked at $522K in Q4 2020.
  • 1,608 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.

Based on Summit X LLC's 13F filing for Q1 2021, filed 10 May 2021.